By Vish Srivastava (Co-Founder & CEO of Century Health)2025-10-20T09:00:12
Vish Srivastava considers the benefits of expanding the role of real-world data in drug discovery to provide improved therapies, faster and with greater success.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2024-01-19T07:40:55
Sponsored by Euretos
2024-01-26T13:22:42
Sponsored by bit.bio
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
2026-03-11T14:00:00
Sponsored by Merck
Site powered by Webvision Cloud